Skip to main content

Boston Scientific Value Stock - Dividend - Research Selection

Boston scientific

ISIN: US1011371077 , WKN: 884113

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy systems, wires, and stents to treat venous diseases; and peripheral embolization devices, microcatheters, and drainage catheters to treat various cancers. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to treat abnormalities; remote patient management system; implantable cardiac resynchronization therapy pacemaker systems; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, mapping system, and other accessories. Further, it provides products to diagnose and treat diseases of the gastrointestinal and pulmonary conditions; devices to diagnose, treat, and palliate pulmonary diseases within the airway and lungs; and products to treat various urological and pelvic conditions; deep brain stimulation systems for the treatment of parkinson\'s disease, tremor, and intractable primary and secondary dystonia; and spinal cord stimulator systems for the management of chronic pain. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


BSX November 17th Options Begin Trading

2023-03-16
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Boston Scientific Corp. stock rises Thursday, still underperforms market

2023-03-16
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Boston Scientific Corp. stock falls Wednesday, underperforms market

2023-03-15
Shares of Boston Scientific Corp. slipped 0.70% to $47.97 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the...

Boston Scientific Corp. stock rises Tuesday, still underperforms market

2023-03-14
Shares of Boston Scientific Corp. advanced 1.49% to $48.31 Tuesday, on what proved to be an all-around positive trading session for the stock market, with...

A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

2023-03-14
Key Insights Using the 2 Stage Free Cash Flow to Equity, Boston Scientific fair value estimate is US$47.70 With...

Boston Scientific Corp. stock outperforms market on strong trading day

2023-03-13
Shares of Boston Scientific Corp. rose 2.41% to $47.60 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P...

Boston Scientific Corp. stock underperforms Friday when compared to competitors

2023-03-10
Shares of Boston Scientific Corp. shed 1.23% to $46.48 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...

Boston Scientific Corp. stock outperforms competitors on strong trading day

2023-03-09
Shares of Boston Scientific Corp. inched 0.36% higher to $47.06 Thursday, on what proved to be an all-around grim trading session for the stock market, with...

Stocks most susceptible to a stronger Wealth Effect - BofA

2023-03-09
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Boston Scientific: Three of My Teachable Moments on Embracing Equity

2023-03-08
NORTHAMPTON, MA / ACCESSWIRE / March 8, 2023 / Boston Scientific Leaders play a crucial role in cultivating a culture of equity and inclusion. If culture was soil, what are the fertilizers that leaders would need to mix in for equity to blossom? ...